NM_207122.2:c.666C>G
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_207122.2(EXT2):c.666C>G(p.Tyr222*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_207122.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- exostoses, multiple, type 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
- seizures-scoliosis-macrocephaly syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- hereditary multiple osteochondromasInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_207122.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EXT2 | NM_207122.2 | MANE Select | c.666C>G | p.Tyr222* | stop_gained | Exon 4 of 14 | NP_997005.1 | ||
| EXT2 | NM_000401.3 | c.765C>G | p.Tyr255* | stop_gained | Exon 4 of 14 | NP_000392.3 | |||
| EXT2 | NM_001178083.3 | c.666C>G | p.Tyr222* | stop_gained | Exon 4 of 15 | NP_001171554.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EXT2 | ENST00000533608.7 | TSL:1 MANE Select | c.666C>G | p.Tyr222* | stop_gained | Exon 4 of 14 | ENSP00000431173.2 | ||
| EXT2 | ENST00000358681.8 | TSL:1 | c.666C>G | p.Tyr222* | stop_gained | Exon 4 of 15 | ENSP00000351509.4 | ||
| EXT2 | ENST00000343631.4 | TSL:1 | c.666C>G | p.Tyr222* | stop_gained | Exon 5 of 15 | ENSP00000342656.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461832Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Exostoses, multiple, type 2;C4225248:Seizures-scoliosis-macrocephaly syndrome Pathogenic:1
Exostoses, multiple, type 2 Pathogenic:1
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 30334991, 9326317)
EXT2-related disorder Pathogenic:1
The EXT2 c.666C>G variant is predicted to result in premature protein termination (p.Tyr222*). This variant has been reported in several affected members of a family with hereditary multiple osteochondromas (Family 2, Philippe et al. 1997. PubMed ID: 9326317), and also in an individual from an unrelated family with hereditary multiple osteochondromas (Li et al. 2018. PubMed ID: 30334991. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in EXT2 are expected to be pathogenic. This variant is interpreted as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at